Joshi Pranav, Kang Soo-Yeon, Datar Akshata, Lee Moo-Yeal
Department of Chemical and Biomedical Engineering, Cleveland State University, Cleveland, Ohio.
Curr Protoc Toxicol. 2019 Feb;79(1):e66. doi: 10.1002/cptx.66. Epub 2018 Nov 2.
High-content imaging (HCI) assays on two-dimensional (2D) cell cultures often do not represent in vivo characteristics accurately, thus reducing the predictability of drug toxicity/efficacy in vivo. On the other hand, conventional 3D cell cultures are relatively low throughput and possess difficulty in cell imaging. To address these limitations, a miniaturized 3D cell culture has been developed on a micropillar/microwell chip platform with human cells encapsulated in biomimetic hydrogels. Model compounds are used to validate human cell microarrays for high-throughput assessment of mechanistic toxicity. Main mechanisms of toxicity of compounds can be investigated by analyzing multiple parameters such as DNA damage, mitochondrial impairment, intracellular glutathione level, and cell membrane integrity. IC values of these parameters can be determined and compared for the compounds to investigate the main mechanism of toxicity. This paper describes miniaturized HCI assays on 3D-cultured cell microarrays for high-throughput assessment of mechanistic profiles of compound-induced toxicity. © 2018 by John Wiley & Sons, Inc.
在二维(2D)细胞培养上进行的高内涵成像(HCI)分析通常不能准确代表体内特征,从而降低了药物在体内毒性/疗效的可预测性。另一方面,传统的三维(3D)细胞培养通量相对较低,且细胞成像存在困难。为了解决这些局限性,已在微柱/微孔芯片平台上开发了一种小型化的3D细胞培养,其中人类细胞封装在仿生水凝胶中。使用模型化合物来验证用于高通量评估机制毒性的人类细胞微阵列。化合物毒性的主要机制可通过分析多个参数来研究,如DNA损伤、线粒体损伤、细胞内谷胱甘肽水平和细胞膜完整性。可以确定这些参数的IC值并对化合物进行比较,以研究毒性的主要机制。本文描述了在3D培养的细胞微阵列上进行的小型化HCI分析,用于高通量评估化合物诱导毒性的机制概况。© 2018 John Wiley & Sons, Inc.